Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · February 05, 2022

Re-Induction With IV Ustekinumab in Patients With Crohn's Disease

Inflammatory Bowel Diseases


Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
Inflamm. Bowel Dis. 2022 Jan 05;28(1)41-47, F Bermejo, L Jiménez, A Algaba, M Vela, G Bastida, O Merino, A López-García, L Melcarne, I Rodríguez-Lago, S de la Maza, A Bouhmidi, M Barreiro-de Acosta, P López-Serrano, M Carrillo-Palau, F Mesonero, B Orts, D Bonillo, A Granja, I Guerra

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading